Linzi Arndt

Linzi Arndt

Auto-generated profile, based on publicly available information

Linzi Arndt

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2023 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
AVAlexander Villalobos
Alexander Villalobos
LALinzi Arndt
Linzi Arndt
BCBernard Cheng
Bernard Cheng
HDHoward Dabbous
Howard Dabbous
MLMohammed Loya
Mohammed Loya
NKNima Kokabi
Nima Kokabi

23 November 2020 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
LALinzi Arndt
Linzi Arndt
AVAlexander Villalobos
Alexander Villalobos
WWWilliam Wagstaff
William Wagstaff
BCBernard Cheng
Bernard Cheng
MXMinzhi Xing
Minzhi Xing
NKNima Kokabi
Nima Kokabi

21 May 2024 in Clinical Nuclear Medicine
Verified
Journal Article
Open access
NKNima Kokabi
Nima Kokabi
LWLinzi A. Webster
Linzi A. Webster
HDHoward Hussein Dabbous
Howard Hussein Dabbous
ASAnand Shah
Anand Shah
DBDavid Brandon
David Brandon
DSDavid Schuster
David Schuster
Background: Personalized dosimetry improves overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with glass 90Y radioembolization. This study evaluated personalized tumor dose (TD) as a predictor of OS, progression-free survival (PFS), and local duration of response (DOR) in patients with surgically unresectable HCC treated with resin 90Y radioembolization. Patients and Methods: This prospective, single-center, single-arm clinical trial (NCT04172714) evaluated the efficacy of scout activity of resin 90Y versus 99mTc-MAA for treatment planning. A secondary aim of this study was to evaluate personalized dosimetry as a predictor of OS, PFS, and DOR. Partition dosimetry model was utilized for nonsegmental therapies with targeted TD >200 Gy and nontumoral liver dose 250 Gy resulted in prolonged mean OS and PFS. The median local DOR was 32.7 months with mean TD 330 Gy predicting prolonged DOR. Interpretation: For patients with surgically unresectable HCC treated with resin 90Y, there is mean TD threshold predicting prolonged OS, PFS, and local DOR. Therefore, there should be further emphasis on personalized dosimetry for optimization of patient outcomes.

1 April 2022 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
LWLinzi A. Webster
Linzi A. Webster
JNJanice Newsome
Janice Newsome
MGMian Guo
Mian Guo
SLScott Lee
Scott Lee
BMBill Majdalany
Bill Majdalany
NKNima Kokabi
Nima Kokabi

12 September 2019 in Emergency Radiology
Verified
Journal Article
Closed access
PDF file
LALinzi Arndt
Linzi Arndt
DMDanial Mir
Danial Mir
JNJohnathan Nguyen
Johnathan Nguyen
NNNariman Nezami
Nariman Nezami
SDSean R Dariushnia
Sean R Dariushnia
NKNima Kokabi
Nima Kokabi

30 November 2022 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
LWLinzi A. Webster
Linzi A. Webster
AVAlex Villalobos
Alex Villalobos
BCBernard Cheng
Bernard Cheng
MXMinzhi Xing
Minzhi Xing
BMBill S. Majdalany
Bill S. Majdalany
NKNima Kokabi
Nima Kokabi